Command Palette

Search for a command to run...

Clinical Trials · NCT05786521

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment
20
Start date
Apr 2023
Locations
1 site, United States
Primary endpoint
Lean Body Mass Change
View Semaglutide compound reference